Pharmaceutical tablet
Latest Celgene Corporation Patents:
- TRANSGENIC MOUSE EXPRESSING HUMAN CEREBLON
- Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases
- Compounds and Compositions for Selective Degradation of Engineered Proteins
- Cereblon binding compounds, compositions thereof, and methods of treatment therewith
- Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione
Claims
The ornamental design for a pharmaceutical tablet, as shown and described.
D31133 | July 1899 | Lantz |
D302051 | July 4, 1989 | Contractor |
5770225 | June 23, 1998 | Parekh |
5824338 | October 20, 1998 | Jacobs |
D403396 | December 29, 1998 | Lundbom |
D425614 | May 23, 2000 | Chen |
D430285 | August 29, 2000 | Chen |
6165513 | December 26, 2000 | Dansereau |
D459798 | July 2, 2002 | Desesquelle |
D506544 | June 21, 2005 | Rinker |
D534646 | January 2, 2007 | Chang |
D535021 | January 9, 2007 | Stawski |
D564086 | March 11, 2008 | Nielsen |
D671636 | November 27, 2012 | Nishino |
D735315 | July 28, 2015 | Bhat |
D741990 | October 27, 2015 | Ramos |
Type: Grant
Filed: Jun 23, 2015
Date of Patent: May 16, 2017
Assignee: Celgene Corporation (Summit, NJ)
Inventors: Darshan Parikh (Bridgewater, NJ), Scott Burnside (Wilmington, NC), Sreenivas S. Bhat (Kendall Park, NJ), Jiping Liu (Basking Ridge, NJ)
Primary Examiner: Charles Hanson
Application Number: 29/531,113